Abstract
ANCA-associated vasculitis (AAV) is characterized by granulomatous and neutrophilic tissue inflammation, and is commonly accompanied with the development of antibodies that target neutrophil antigens. The two major antigens targeted by ANCAs are leukocyte proteinase 3 (PR3) and myeloperoxidase (MPO). The development of AAV has been linked to a number of potential risk aspects, including ecological, pharmacological, and microbial exposures. Infectious (microbial) factors are thought towards show a part in many types of vasculitis by causing inflammation of vessel walls as a result of direct or contiguous infection, type II or immune complex-mediated reaction, cell mediated allergic reaction, or inflammation caused by immune dysregulation triggered by bacterial toxin and/or super antigen production. Because immune suppressive medication in the absence of antimicrobial therapy may enhance morbidity while failing to resolve infection-related vascular inflammation, infectious entities should be considered as a potential inciting factor in vasculitis disorders. Therefore, amid these factors, here we contribute new consideration on infectious factors associated vasculitis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Aimo A, Migliorini P, Vergaro G, Franzini M, Passino C, Maisel A, Emdin M (2018) The IL-33/ST2 pathway, inflammation and atherosclerosis: trigger and target? Int J Cardiol 267:188–192. https://doi.org/10.1016/j.ijcard.2018.05.056
Aiyegbusi O, Frleta-Gilchrist M, Traynor JP, Mackinnon B, Bell S, Hunter RW et al (2021) ANCA-associated renal vasculitis is associated with rurality but not seasonality or deprivation in a complete national cohort study. RMD Open 7(2):e001555. https://doi.org/10.1136/rmdopen-2020-001555
Alexander-Kaufman K, Harper C (2009) Transketolase: observations in alcohol-related brain damage research. Int J Biochem Cell Biol 41(4):717–720. https://doi.org/10.1016/j.biocel.2008.04.005
Asano S, Mizuno S, Okachi S, Aso H, Wakahara K, Hashimoto N et al (2016) Antineutrophil cytoplasmic antibody-associated Vasculitis superimposed on infection-related glomerulonephritis secondary to pulmonary Mycobacterium avium complex infection. Intern Med 55(17):2439–2445. https://doi.org/10.2169/internalmedicine.55.6588
Balakrishnan N, Ericson M, Maggi R, Breitschwerdt EB (2016) Vasculitis, cerebral infarction and persistent Bartonella henselae infection in a child. Parasit Vectors 9(1):1–6. https://doi.org/10.1186/s13071-016-1547-9
Berti A, Cavalli G, Campochiaro C, Guglielmi B, Baldissera E, Cappio S et al (2015) Interleukin-6 in ANCA-associated vasculitis: rationale for successful treatment with tocilizumab. Semin Arthritis Rheum 45(1):48–54. https://doi.org/10.1016/j.semarthrit.2015.02.002
Berti A, Warner R, Johnson K, Cornec D, Schroeder D, Kabat B et al (2018) Brief report: circulating cytokine profiles and antineutrophil cytoplasmic antibody specificity in patients with antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis Rheumatol 70(7):1114–1121. https://doi.org/10.1002/art.40471
Berti A, Warner R, Johnson K, Cornec D, Schroeder DR, Kabat BF et al (2019) The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis. J Autoimmun 105:102302. https://doi.org/10.1016/j.jaut.2019.07.001
von Borstel A, Sanders JS, Rutgers A, Stegeman CA, Heeringa P, Abdulahad WH (2018) Cellular immune regulation in the pathogenesis of ANCA-associated vasculitides. Autoimmun Rev 17(4):413–421. https://doi.org/10.1016/j.autrev.2017.12.002
Bossuyt X, Tervaert JWC, Arimura Y, Blockmans D, Flores-Suárez LF, Guillevin L et al (2017) Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol 13(11):683–692. https://doi.org/10.1038/nrrheum.2017.140
Brilland B, Garnier AS, Chevailler A, Jeannin P, Subra JF, Augusto JF (2020) Complement alternative pathway in ANCA-associated vasculitis: two decades from bench to bedside. Autoimmun Rev 19(1):102424. https://doi.org/10.1016/j.autrev.2019.102424
Brinkmann V, Reichard U, Goosmann C et al (2004) Neutrophil extracellular traps kill bacteria. Science 303(5663):1532–1535. https://doi.org/10.1126/science.1092385
Brunini F, Page TH, Gallieni M, Pusey CD (2016) The role of monocytes in ANCA-associated vasculitides. Autoimmun Rev 15(11):1046–1053. https://doi.org/10.1016/j.autrev.2016.07.031
Butler NJ, Furtado JM, Winthrop KL, Smith JR (2013) Ocular toxoplasmosis II: clinical features, pathology and management. Clin Exp Ophthalmol 41(1):95–108
Carpenter S, Cohen Tervaert JW, Yacyshyn E (2020) Advances in therapeutic treatment options for ANCA-associated vasculitis. Exp Opin Orphan Drugs 8(4):127–136. https://doi.org/10.1080/21678707.2020.1760837
Casselman BL, Kilgore KS, Miller BF, Warren JS (1995) Antibodies to neutrophil cytoplasmic antigens induce monocyte chemoattractant protein-1 secretion from human monocytes. J Lab Clin Med 126(5):495–502
Chauhan R, Jain D, Tiwari AK, Dorwal P, Raina V, Nandi SP (2020) Laboratory diagnosis of ANCA-associated vasculitis (AAV) using a combination of immunofluorescence test (IIFT) and line immunoassay (LIA): single-centre report from India. Reumatol ClÃn. https://doi.org/10.1016/j.reuma.2020.08.005
Chen M, **ng GQ, Yu F, Liu G, Zhao MH (2009) Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis. Nephrol Dial Transplant 24(4):1247–1252. https://doi.org/10.1093/ndt/gfn586
Chevrier S, Genton C, Kallies A, Karnowski A, Otten LA, Malissen B et al (2009) CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche. Proc Natl Acad Sci 106(10):3895–3900. https://doi.org/10.1073/pnas.0809736106
Choi M, Eulenberg C, Rolle S, Von Kries JP, Luft FC, Kettritz R (2010) The use of small molecule high-throughput screening to identify inhibitors of the proteinase 3-NB1 interaction. Clin Exp Immunol 161(2):389–396. https://doi.org/10.1111/j.1365-2249.2010.04174.x
Coit P, Mumcu G, Ture-Ozdemir F, Unal AU, Alpar U, Bostanci N et al (2016) Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Behcet’s disease. Clin Immunol 169:28–35. https://doi.org/10.1016/j.clim.2016.06.002
Collins A, Azmat F, Rentschler R (2019) ‘Bringing everyone on the same journey’: revisiting inclusion in higher education. Stud High Educ 44(8):1475–1487. https://doi.org/10.1080/03075079.2018.1450852
Csernok E, Trabandt A, Müller A, Wang GC, Moosig F, Paulsen J et al (1999) Cytokine profiles in Wegener’s granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis Rheum 42(4):742–750. https://doi.org/10.1002/1529-0131(199904)42:4<742::AID-ANR18>3.0.CO;2-I
Csernok E, Holle JU, Gross WL (2008) Proteinase 3, protease-activated receptor-2 and interleukin-32: linking innate and autoimmunity in Wegener’s granulomatosis. Clin Exp Rheumatol 26(3 Suppl 49):S112–S117
van Dam LS, Dirikgil E, Bredewold EW, Ray A, Bakker JA, van Kooten C, Teng YKO (2021) PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab. Nephrol Dial Transplant 36(8):1408–1417. https://doi.org/10.1093/ndt/gfaa066
DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E (2016) Current understanding of dysbiosis in disease in human and animal models. Inflamm Bowel Dis 22(5):1137–1150. https://doi.org/10.1097/MIB.0000000000000750
Dinarello C, Novick D, Kim S, Kaplanski G (2013) Interleukin-18 and IL-18 binding protein. Front Immunol 4:289. https://doi.org/10.3389/fimmu.2013.00289
Dolff S, Witzke O, Wilde B (2019) Th17 cells in renal inflammation and autoimmunity. Autoimmun Rev 18(2):129–136. https://doi.org/10.1016/j.autrev.2018.08.006
Dua J, Nandagudi A, Sutcliffe N (2012) Mycoplasma pneumoniae infection associated with urticarial vasculitis mimicking adult-onset Still’s disease. Rheumatol Int 32(12):4053–4056
Dumoitier N, Terrier B, London J, Lofek S, Mouthon L (2015) Implication of B lymphocytes in the pathogenesis of ANCA-associated vasculitides. Autoimmun Rev 14(11):996–1004. https://doi.org/10.1016/j.autrev.2015.06.008
Edelstein H, Cutting HO (1986) Escherichia coli as cause of ecthyma gangrenosum. Postgrad Med 79(2):44–45
Eriksson P, Sandell C, Backteman K, Ernerudh J (2012) Expansions of CD4+ CD28–and CD8+ CD28–T cells in granulomatosis with polyangiitis and microscopic polyangiitis are associated with cytomegalovirus infection but not with disease activity. J Rheumatol 39(9):1840–1843. https://doi.org/10.3899/jrheum.120060
Everts-Graber J, Martin KR, Thieblemont N, Mocek J, Roccabianca A, Chafey P et al (2019) Proteomic analysis of neutrophils in ANCA-associated vasculitis reveals a dysregulation in proteinase 3-associated proteins such as annexin-A1 involved in apoptotic cell clearance. Kidney Int 96(2):397–408. https://doi.org/10.1016/j.kint.2019.02.017
Falk RJ, Terrell RS, Charles LA, Jennette JC (1990) Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci 87(11):4115–4119. https://doi.org/10.1073/pnas.87.11.4115
Fergie JE, Huang DB, Purcell K, Milligan T (2000) Successful treatment Offusarium solaniecthyma gangrenosum in a child with acute lymphoblastic leukemia in relapse. Pediatr Infect Dis J 19(6):579–581. https://journals.lww.com/pidj/2000/06000
Finkel TH, Torok TJ, Ferguson PJ et al (1994) Chronic parvovirus B19 infection and systemic necrotizing vasuclitis: opportunistic infection or aetiological agent? Lancet 343:1255–1258
Free ME, Bunch DOD, McGregor JA, Jones BE, Berg EA, Hogan SL et al (2013) Patients with antineutrophil cytoplasmic antibody–associated vasculitis have defective treg cell function exacerbated by the presence of a suppression-resistant effector cell population. Arthritis Rheum 65(7):1922–1933
Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group (2008) Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial. Transplantation 86(9):1187–1195. https://doi.org/10.1097/TP.0b013e318187bab0
Gabillet J, Millet A, Pederzoli-Ribeil M, Tacnet-Delorme P, Guillevin L, Mouthon L et al (2012) Proteinase 3, the autoantigen in granulomatosis with polyangiitis, associates with calreticulin on apoptotic neutrophils, impairs macrophage phagocytosis, and promotes inflammation. J Immunol 189(5):2574–2583. https://doi.org/10.4049/jimmunol.1200600
Gaeggeler HP, Gonzalez-Rodriguez E, Jaeger NF, Loffing-Cueni D, Norregaard R, Loffing J et al (2005) Mineralocorticoid versus glucocorticoid receptor occupancy mediating aldosterone-stimulated sodium transport in a novel renal cell line. J Am Soc Nephrol 16(4):878–891. https://doi.org/10.1681/asn.2004121110
Gan PY, Tan DS, Ooi JD, Alikhan MA, Kitching AR, Holdsworth SR (2016) Myeloperoxidase peptide–based nasal tolerance in experimental ANCA–associated GN. J Am Soc Nephrol 27(2):385–391. https://doi.org/10.1681/ASN.2015010089
Gilden D, White T, Boyer PJ, Galetta KM, Hedley-Whyte ET, Frank M et al (2016) Varicella zoster virus infection in granulomatous arteritis of the aorta. J Infect Dis 213(12):1866–1871. https://doi.org/10.1093/infdis/jiw101
Gornik HL, Creager MA (2008) Aortitis. Circulation 117(23):3039–3051
Gou SJ, Yuan J, Chen M, Yu F, Zhao MH (2013) Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody–associated vasculitis. Kidney Int 83(1):129–137. https://doi.org/10.1038/ki.2012.313
Guillevin L (2004) Virus-induced systemic vasculitides: new therapeutic approaches. Clin Dev Immunol 11(2):227–231. https://doi.org/10.1080/17402520400001744
Hao J, Meng LQ, Xu PC, Chen M, Zhao MH (2012) p38MAPK, ERK and PI3K signaling pathways are involved in C5a-primed neutrophils for ANCA-mediated activation. PLoS One 7(5):e38317. https://doi.org/10.1371/journal.pone.0038317
Harris RL, Fainstein V, Elting L, Hopfer RL, Bodey GP (1985) Bacteremia caused by Aeromonas species in hospitalized cancer patients. Rev Infect Dis 7(3):314–320. https://doi.org/10.1093/clinids/7.3.314
Hattar K, Van Bürck S, Bickenbach A, Grandel U, Maus U, Lohmeyer J et al (2005) Anti-proteinase 3 antibodies (c-ANCA) prime CD14-dependent leukocyte activation. J Leukoc Biol 78(4):992–1000
Hellmich B, Csernok E, Trabandt A, Gross WL, Ernst M (2000) Granulocyte-macrophage colony-stimulating factor (GM-CSF) but not granulocyte colony-stimulating factor (G-CSF) induces plasma membrane expression of proteinase 3 (PR3) on neutrophils in vitro. Clin Exp Immunol 120(2):392–398. https://doi.org/10.1046/j.1365-2249.2000.01205.x
Hewins P, Morgan MD, Holden N, Neil D, Williams JM, Savage COS, Harper L (2006) IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis. Kidney Int 69(3):605–615. https://doi.org/10.1038/sj.ki.5000167
Holden NJ, Williams JM, Morgan MD, Challa A, Gordon J, Pepper RJ et al (2011) ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process. Ann Rheum Dis 70(12):2229–2233. https://doi.org/10.1136/ard.2011.153890
Hoshino A, Nagao T, Nagi-Miura N, Ohno N, Yasuhara M, Yamamoto K et al (2008) MPO-ANCA induces IL-17 production by activated neutrophils in vitro via its Fc region-and complement-dependent manner. J Autoimmun 31(1):79–89. https://doi.org/10.1016/j.jaut.2008.03.006
Huugen D, **ao H, van Esch A, Falk RJ, Peutz-Kootstra CJ, Buurman WA et al (2005) Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-α. Am J Pathol 167(1):47–58. https://doi.org/10.1016/s0002-9440(10)62952-5
Icer MA, Gezmen-Karadag M (2018) The multiple functions and mechanisms of osteopontin. Clin Biochem 59:17–24. https://doi.org/10.1016/j.clinbiochem.2018.07.003
Ito Y, Uemura K (2016) Successful treatment of Bordetella bronchiseptica pneumonia by minocycline in anti-neutrophil cytoplasmic antibodies-associated vasculitis patient. J Infect Chemother 22(12):808–810
Jang TN, Wang FD, Wang LS, Liu CY, Liu IM (1992) Xanthomonas maltophilia bacteremia: an analysis of 32 cases. J Formos Med Assoc 91(12):1170–1176. https://europepmc.org/article/med/1363639
Jayne D (2019) Complement inhibition in ANCA vasculitis. Nephrol Therapeut 15(6):409–412. https://doi.org/10.1016/j.nephro.2019.04.001
Jayne D (2021) Antineutrophil cytoplasmic antibody-associated vasculitis management 2020: where are we now? J Rheumatol 48:479. https://doi.org/10.3899/jrheum.201351
Jayne DRW, Chapel H, Adu D, Misbah S, O’donoghue D, Scott D, Lockwood CM (2000) Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM 93(7):433–439. https://doi.org/10.1093/qjmed/93.7.433
Jayne DR, Bruchfeld AN, Harper L, Schaier M, Venning MC, Hamilton P et al (2017) Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis. J Am Soc Nephrol 28(9):2756–2767. https://doi.org/10.1681/ASN.2016111179
Jenh CH, Cox MA, Hipkin W, Lu T, Pugliese-Sivo C, Gonsiorek W et al (2001) Human B cell-attracting chemokine 1 (BCA-1; CXCL13) is an agonist for the human CXCR3 receptor. Cytokine 15(3):113–121. https://doi.org/10.1006/cyto.2001.0923
Jennette JC, Falk RJ (2014a) Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol 10(8):463–473. https://doi.org/10.1038/nrrheum.2014.103
Jennette JC, Falk RJ (2014b) B cell-mediated pathogenesis of ANCA-mediated vasculitis. Semin Immunopathol 36(3):327–338. https://doi.org/10.1007/s00281-014-0431-y
Jerke U, Marino SF, Daumke O, Kettritz R (2017) Characterization of the CD177 interaction with the ANCA antigen proteinase 3. Sci Rep 7(1):1–11. https://doi.org/10.1038/srep43328
Joshi U, Subedi R, Gajurel BP (2017) Hepatitis B virus induced cytoplasmic antineutrophil cytoplasmic antibody-mediated vasculitis causing subarachnoid hemorrhage, acute transverse myelitis, and nephropathy: a case report. J Med Case Rep 11(1):1–5. https://doi.org/10.1186/s13256-017-1255-x
Kallenberg CG (2010) Pathophysiology of ANCA-associated small vessel vasculitis. Curr Rheumatol Rep 12(6):399–405
Kantari C, Pederzoli-Ribeil M, Amir-Moazami O, Gausson-Dorey V, Moura IC, Lecomte MC et al (2007) Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis. Blood 110(12):4086–4095. https://doi.org/10.1074/jbc.M115.698639
Khosravi A, Yáñez A, Price JG, Chow A, Merad M, Goodridge HS, Mazmanian SK (2014) Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host Microbe 15(3):374–381. https://doi.org/10.1016/j.chom.2014.02.006
Koller L, Richter B, Winter MP, Sulzgruber P, Potolidis C, Liebhart F et al (2017) Clusterin/apolipoprotein J is independently associated with survival in patients with chronic heart failure. J Clin Lipidol 11(1):178–184. https://doi.org/10.1161/CIRCHEARTFAILURE.117.004838
Konig MF (2020) The microbiome in autoimmune rheumatic disease. Best Pract Res Clin Rheumatol 34(1):101473. https://doi.org/10.1016/j.berh.2019.101473
Krebs CF, Paust HJ, Krohn S, Koyro T, Brix SR, Riedel JH et al (2016) Autoimmune renal disease is exacerbated by S1P-receptor-1-dependent intestinal Th17 cell migration to the kidney. Immunity 45(5):1078–1092. https://doi.org/10.1016/j.immuni.2016.10.020
Kronbichler A, Leierer J, Leierer G, Mayer G, Casian A, Höglund P et al (2017) Clinical associations with venous thromboembolism in anti-neutrophil cytoplasm antibody-associated vasculitides. Rheumatology 56(5):704–708. https://doi.org/10.1093/rheumatology/kew465
Kronbichler A, Leierer J, Shin JI, Merkel PA, Spiera R, Seo P et al (2019) Association of pulmonary hemorrhage, positive proteinase 3, and urinary red blood cell casts with venous thromboembolism in antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis Rheumatol 71(11):1888–1893. https://doi.org/10.1002/art.41017
Kronbichler A, Lee KH, Denicolò S, Choi D, Lee H, Ahn D et al (2020a) Immunopathogenesis of ANCA-associated vasculitis. Int J Mol Sci 21(19):7319. https://doi.org/10.3390/ijms21197319
Kronbichler A, Leierer J, Gauckler P, Shin JI (2020b) Comorbidities in ANCA-associated vasculitis. Rheumatology 59(Suppl_3):iii79–iii83. https://doi.org/10.1093/rheumatology/kez617
Kuźma-Mroczkowska E, Pańczyk-Tomaszewska M, Szmigielska A, Szymanik-Grzelak H, Roszkowska-Blaim M (2015) Mycoplasma pneumoniae as a trigger for Henoch-Schönlein purpura in children. C Eur J Immunol 40(4):489. https://doi.org/10.5114/ceji.2015.56976
Lawley TD, Walker AW (2013) Intestinal colonization resistance. Immunology 138(1):1–11. https://doi.org/10.1111/j.1365-2567.2012.03616.x
Le Roux S, Pepper RJ, Dufay A, Néel M, Meffray E, Lamandé N et al (2012) Elevated soluble Flt1 inhibits endothelial repair in PR3-ANCA–associated vasculitis. J Am Soc Nephrol 23(1):155–164. https://doi.org/10.1681/ASN.2010080858
Lepse N, Abdulahad WH, Kallenberg CG, Heeringa P (2011) Immune regulatory mechanisms in ANCA-associated vasculitides. Autoimmun Rev 11(2):77–83. https://doi.org/10.1016/j.autrev.2011.08.002
Li J, Cui Z, Long JY, Huang W, Wang JW, Wang H et al (2018) The frequency of ANCA-associated vasculitis in a national database of hospitalized patients in China. Arthritis Res Tther 20(1):1–10. https://doi.org/10.1186/s13075-018-1708-7
Lindner G, Schwarz C, Funk GC (2012) Osmotic diuresis due to urea as the cause of hypernatraemia in critically ill patients. Nephrol Dial Transplant 27(3):962–967. https://doi.org/10.1093/ndt/gfr428
Liu Y, Freeborn J, Armbrister SA, Tran DQ, Rhoads JM (2021) Treg-associated monogenic autoimmune disorders and gut microbial dysbiosis. Pediatr Res 91:1–9. https://doi.org/10.1038/s41390-021-01445-2
Lokau J, Agthe M, Garbers C (2016) Generation of soluble interleukin-11 and interleukin-6 receptors: a crucial function for proteases during inflammation. Mediat Inflamm 2016:1785021. https://doi.org/10.1155/2016/1785021
LúdvÃksson BR, Sneller MC, Chua KS, Talar-Williams C, Langford CA, Ehrhardt RO et al (1998) Active Wegener’s granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. J Immunol 160(7):3602–3609
Mahr A, Guillevin L, Poissonnet M, Aymé S (2004) Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener’s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture–recapture estimate. Arthritis Care Res 51(1):92–99. https://doi.org/10.1002/art.20077
Manasson J, Blank RB, Scher JU (2020) The microbiome in rheumatology: where are we and where should we go? Ann Rheum Dis 79(6):727–733. https://doi.org/10.1136/annrheumdis-2019-216631
Martin KR, Witko-Sarsat V (2017) Proteinase 3: the odd one out that became an autoantigen. J Leukoc Biol 102(3):689–698. https://doi.org/10.1189/jlb.3mr0217-069r
Martinez Valenzuela L, Bordignon Draibe J, Fulladosa Oliveras X, Bestard Matamoros O, Cruzado Garrit JM, Torras Ambrós J (2019) T-lymphocyte in ANCA-associated vasculitis: what do we know? A pathophysiological and therapeutic approach. Clin Kidney J 12(4):503–511. https://doi.org/10.1093/ckj/sfz029
Marvisi C, Galli E, Manzini CU, Sandri G, Salvarani C (2020) EULAR guidelines on ANCA-associated vasculitis in the real life. Beyond Rheumatol 2:74–78. https://doi.org/10.4081/br.2020.50
Masutani K, Tokumoto M, Nakashima H, Tsuruya K, Kashiwagi M, Kudoh Y et al (2003) Strong polarization toward Th1 immune response in ANCA-associated glomerulonephritis. Clin Nephrol 59(6):395–405. https://doi.org/10.5414/cnp59395
McGoldrick SM, Bleakley ME, Guerrero A, Turtle CJ, Yamamoto TN, Pereira SE, Delaney CS, Riddell SR (2013) Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo. Blood J Am Soc Hematol 121(14):2796–2803
Midwood KS, Chiquet M, Tucker RP, Orend G (2016) Tenascin-C at a glance. J Cell Sci 129(23):4321–4327. https://doi.org/10.1242/jcs.190546
Millet A, Martin KR, Bonnefoy F, Saas P, Mocek J, Alkan M et al (2015) Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis. J Clin Invest 125(11):4107–4121. https://doi.org/10.1172/JCI78182
Mine I, Taguchi M, Sakurai Y, Takeuchi M (2017) Bilateral idiopathic retinal vasculitis following coxsackievirus A4 infection: a case report. BMC Ophthalmol 17(1):1–5. https://doi.org/10.1186/s12886-017-0523-2
Mohammad AJ (2020) An update on the epidemiology of ANCA-associated vasculitis. Rheumatology 59(Suppl_3):iii42–iii50. https://doi.org/10.1093/rheumatology/keaa089
Moiseev SV, Novikov PI (2015) Classification, diagnosis and treatment of ANCA-associated vasculitis. World J Rheumatol 5(1):36–44. https://doi.org/10.5499/wjr.v5.i1.36
Monach PA, Warner RL, Tomasson G, Specks U, Stone JH, Ding L et al (2013) Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis. Ann Rheum Dis 72(8):1342–1350. https://doi.org/10.1136/annrheumdis-2012-201981
Moran SM, Monach PA, Zgaga L, Cuthbertson D, Carette S, Khalidi NA et al (2020) Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrol Dial Transplant 35(2):283–291. https://doi.org/10.1093/ndt/gfy300
Morris H, Morgan MD, Wood AM, Smith SW, Ekeowa UI, Herrmann K et al (2011) ANCA-associated vasculitis is linked to carriage of the Z allele of α1 antitrypsin and its polymers. Ann Rheum Dis 70(10):1851–1856. https://doi.org/10.1136/ard.2011.153569
Moschen AR, Adolph TE, Gerner RR, Wieser V, Tilg H (2017) Lipocalin-2: a master mediator of intestinal and metabolic inflammation. Trends Endocrinol Metab 28(5):388–397. https://doi.org/10.1016/j.tem.2017.01.003
Mueller A, Holl-Ulrich K, Gross WL (2013) Granuloma in ANCA-associated vasculitides: another reason to distinguish between syndromes? Curr Rheumatol Rep 15(11):376. https://doi.org/10.1007/s11926-013-0376-5
Nishide M, Nojima S, Ito D, Takamatsu H, Koyama S, Kang S et al (2017) Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitis. Ann Rheum Dis 76(8):1440–1448. https://doi.org/10.1136/annrheumdis-2016-210706
Nogueira E, Hamour S, Sawant D, Henderson S, Mansfield N, Chavele KM et al (2010) Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 25(7):2209–2217. https://doi.org/10.1093/ndt/gfp783
Noronha IL, Krüger C, Andrassy K, Ritz E, Waldherr R (1993) In situ production of TNF-α, IL-1β and IL-2R in ANCA-positive glomerulonephritis. Kidney Int 43(3):682–692. https://doi.org/10.1038/ki.1993.98
Ogunrinola GA, Oyewale JO, Oshamika OO, Olasehinde GI (2020) The human microbiome and its impacts on health. Int J Microbiol 2020:8045646. https://doi.org/10.1155/2020/8045646
Ooi JD, Chang J, Hickey MJ, Borza DB, Fugger L, Holdsworth SR, Kitching AR (2012) The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis. Proc Natl Acad Sci 109(39):E2615–E2624. https://doi.org/10.1073/pnas.1210147109
Pendergraft WF III, Niles JL (2014) Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. Curr Opin Rheumatol 26(1):42–49. https://doi.org/10.1097/BOR.0000000000000014
Pepper RJ, Draibe JB, Caplin B, Fervenza FC, Hoffman GS, Kallenberg CG, RAVE–Immune Tolerance Network Research Group (2017) Association of serum calprotectin (S100A8/A9) level with disease relapse in proteinase 3–antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis Rheumatol 69(1):185–193. https://doi.org/10.1002/art.39814
Popa ER, Stegeman CA, Bos NA, Kallenberg CG, Tervaert JWC (1999) Differential B-and T-cell activation in Wegener’s granulomatosis. J Allergy Clin Immunol 103(5):885–894. https://doi.org/10.1016/s0091-6749(99)70434-3
Popa ER, Franssen CFM, Limburg PC, Huitema MG, Kallenberg CGM, Cohen Tervaert JW (2002) In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3-and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase. Arthritis Rheumatol 46(7):1894–1904. https://doi.org/10.1002/art.10384
Porges AJ, Redecha PB, Kimberly WT, Csernok E, Gross WL, Kimberly RP (1994) Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. J Immunol 153(3):1271–1280
Rees LE, Ayoub O, Haverson K, Birchall MA, Bailey M (2003) Differential major histocompatibility complex class II locus expression on human laryngeal epithelium. Clin Exp Immunol 134(3):497–502. https://doi.org/10.1111/j.1365-2249.2003.02301.x
Reich JM (1993) Pulmonary gangrene and the air crescent sign. Thorax 48(1):70–74. https://doi.org/10.1136/thx.48.1.70
Richard KA, Anders HJ, Basu N, Brouwer E, Gordon J, Jayne DR et al (2020) ANCA-associated vasculitis (Primer). Nat Rev Dis Prim 6(1):71. https://doi.org/10.1038/s41572-020-0204-y
Rodrigues JC, Collister D, Archer A, Cheema K, Alexander P, Pagnoux C, Walsh M (2017) P1_185 the steroid tapering in ANCA vasculitis evaluation study (STAVE) 2: a systematic review and meta-analysis. Rheumatology 56(Suppl_3):iii103. https://doi.org/10.1093/rheumatology/kex110
RodrÃguez-Pla A, Stone JH (2006) Vasculitis and systemic infections. Curr Opin Rheumatol 18(1):39–47. https://doi.org/10.1097/01.bor.0000197999.58073.2e
van Roeyen CR, Ostendorf T, Floege J (2012) The platelet-derived growth factor system in renal disease: an emerging role of endogenous inhibitors. Eur J Cell Biol 91(6–7):542–551. https://doi.org/10.1016/j.ejcb.2011.07.003
Ruth AJ, Kitching AR, Kwan RY, Odobasic D, Ooi JD, Timoshanko JR et al (2006) Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis. J Am Soc Nephrol 17(7):1940–1949. https://doi.org/10.1681/asn.2006020108
Richards AL (2012) Worldwide detection and identification of new and old rickettsiae and rickettsial diseases. FEMS Immunol Med Microbiol 64(1):107–110
Saad R, Tsoi K, Onac IA, Davies KA, Hajela VK, Tacu C (2021) Streptococcus-associated vasculitis: a role for antibiotic therapy? IDCases 24:e01071
Salvadori M, Tsalouchos A (2018) Epidemiology and pathogenesis of ANCA associated vasculitis. Reviews in immunology. SM Group Books, Toscana
Schreiber A, **ao H, Jennette JC, Schneider W, Luft FC, Kettritz R (2009) C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. J Am Soc Nephrol 20(2):289–298. https://doi.org/10.1681/asn.2008050497
Seino KI, Iwabuchi K, Kayagaki N, Miyata R, Nagaoka I, Matsuzawa A et al (1998) Cutting edge: chemotactic activity of soluble Fas ligand against phagocytes. J Immunol 161(9):4484–4488
Shan L, Leung K, Zhang H, Cheng KT, Pagel M (2004) Molecular imaging and contrast agent database (MICAD). National Center for Biotechnology Information, Bethesda, MD
Shi Y, Mu L (2017) An expanding stage for commensal microbes in host immune regulation. Cell Mol Immunol 14(4):339–348. https://doi.org/10.1038/cmi.2016.64
Shi XD, Li WY, Shao X, Qu LM, Jiang ZY (2020) Infective endocarditis mimicking ANCA-associated vasculitis: does it require immunosuppressive therapy?: a case report and literature review. Medicine 99(29):e21358. https://doi.org/10.1097/MD.000000000002138
Snider SB, Jacobs CS, Scripko PS, Klein JP, Lyons JL (2014) Hemorrhagic and ischemic stroke secondary to herpes simplex virus type 2 meningitis and vasculopathy. J Neurovirol 20(4):419–422
Singh H, Tanwar VS, Sukhija G, Kaur P, Govil N (2016) Vasculitis as a presenting manifestation of chronic hepatitis B virus infection: a case report. J Clin Diagn Res 10(2):OD25. http://www.jcdr.net/
Stegeman CA, Cohen Tervaert JW, de Jong PE, Kallenberg CG (1996) Trimethoprim–sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener’s granulomatosis. N Engl J Med 335(1):16–20. https://doi.org/10.1056/NEJM199607043350103
Stotka JL, Rupp ME (1991) Klebsiella pneumoniae urinary tract infection complicated by endophthalmitis, perinephric abscess, and ecthyma gangrenosum. South Med J 84(6):790–793. https://doi.org/10.1097/00007611-199106000-00032
Szczeklik W, Jakieła B, Wawrzycka-Adamczyk K, Sanak M, Hubalewska-Mazgaj M, Padjas A et al (2017) Skewing toward Treg and Th2 responses is a characteristic feature of sustained remission in ANCA-positive granulomatosis with polyangiitis. Eur J Immunol 47(4):724–733. https://doi.org/10.1002/eji.201646810
Tan DS, Gan PY, O’Sullivan KM, Hammett MV, Summers SA, Ooi JD, Holdsworth SR (2013) Thymic deletion and regulatory T cells prevent antimyeloperoxidase GN. J Am Soc Nephrol 24(4):573–585
Tarzi RM, Liu J, Schneiter S, Hill NR, Page TH, Cook HT et al (2015) CD14 expression is increased on monocytes in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis and correlates with the expression of ANCA autoantigens. Clin Exp Immunol 181(1):65–75. https://doi.org/10.1111/cei.12625
Teng GG, Chatham WW (2015) Vasculitis related to viral and other microbial agents. Best Pract Res Clin Rheumatol 29(2):226–243
Tervaert JWC (2018) Trimethoprim-sulfamethoxazole and antineutrophil cytoplasmic antibodies-associated vasculitis. Curr Opin Rheumatol 30(4):388–394
Tesmer LA, Lundy SK, Sarkar S, Fox DA (2008) Th17 cells in human disease. Immunol Rev 223(1):87–113. https://doi.org/10.1111/j.1600-065X.2008.00628.x
Tidman M, Olander R, Svalander C (1998a) Daniels-son D: patients hospitalised because of small vessel vasculitis with renal involvement in the period 1975–1995: organ involvement, antineutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies. J Intern Med 244:133–141. https://doi.org/10.1046/j.1365-2796.1998.00324.x
Tidman M, Olander R, Svalander C, Danielsson D (1998b) Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies. J Intern Med 244(2):133–141. https://doi.org/10.1046/j.1365-2796.1998.00324.x
Tieu J, Smith R, Basu N, Brogan P, D’Cruz D, Dhaun N et al (2020) Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines. Rheumatology 59(4):e24–e32. https://doi.org/10.1093/rheumatology/kez640
Vogt W (1996) Complement activation by myeloperoxidase products released from stimulated human polymorphonuclear leukocytes. Immunobiology 195(3):334–346. https://doi.org/10.1016/s0171-2985(96)80050-7
Walker DH, Mattern WD (1980) Rickettsial vasculitis. Am Heart J 100(6):896–906. https://doi.org/10.1016/0002-8703(80)90072-1
Wang JC (2005) Importance of plasma matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinase (TIMP) in development of fibrosis in agnogenic myeloid metaplasia. Leuk Lymphoma 46(9):1261–1268. https://doi.org/10.1080/10428190500126463
Wang X, Abraham S, McKenzie JA, Jeffs N, Swire M, Tripathi VB et al (2013) LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling. Nature 499(7458):306–311. https://doi.org/10.1038/nature12345
Watanabe R, Maeda T, Zhang H, Berry GJ, Zeisbrich M, Brockett R et al (2018) MMP (Matrix Metalloprotease)-9–producing monocytes enable T cells to invade the vessel wall and cause vasculitis. Circ Res 123(6):700–715. https://doi.org/10.1161/CIRCRESAHA.118.313206
Weiner M, Segelmark M (2016) The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA). Autoimmun Rev 15(10):978–982. https://doi.org/10.1016/j.autrev.2016.07.016
Wilde B, Thewissen M, Damoiseaux J, van Paassen P, Witzke O, Tervaert JWC (2010) T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells? Arthritis Res Tther 12(1):1–9. https://doi.org/10.1186/ar2923
Wilde B, Hoerning A, Kribben A, Witzke O, Dolff S (2014) Abnormal expression pattern of the IL-2 receptor β-chain on CD4+ T cells in ANCA-associated vasculitis. Dis Markers 2014:249846. https://doi.org/10.1155/2014/249846
**ao H, Schreiber A, Heeringa P, Falk RJ, Jennette JC (2007) Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 170(1):52–64. https://doi.org/10.2353/ajpath.2007.060573
Yang L, **e H, Liu Z, Chen Y, Wang J, Zhang H, Ge Y, Hu W (2018) Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study. BMC Nephrol 19(1):1–7
Yaqinuddin A, Kashir J (2020) The central role of neutrophil extracellular traps in SARS-CoV-2-induced thrombogenesis and vasculitis. Afr J Respir Med 15(2):1
Yates M, Watts R, Bajema I, Cid M, Crestani B, Hauser T et al (2016) OP0053 Eular/ERA-EDTA recommendations for the management of anca-associated vasculitis. Ann Rheum Dis 75:1583. https://doi.org/10.1136/annrheumdis-2016-eular.1168
Zeng MY, Inohara N, Nuñez G (2017) Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol 10(1):18–26. https://doi.org/10.1038/mi.2016.75
Ziegler U, Angenvoort J, Fischer D, Fast C, Eiden M, Rodriguez AV, Groschup MH (2013) Pathogenesis of West Nile virus lineage 1 and 2 in experimentally infected large falcons. Vet Microbiol 161(3–4):263–273. https://doi.org/10.1016/j.vetmic.2012.07.041
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Selvakumar, V. et al. (2022). Microorganisms in Pathogenesis and Management of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis. In: Dwivedi, M.K., Sankaranarayanan, A., Kemp, E.H., Shoenfeld, Y. (eds) Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-19-4800-8_16
Download citation
DOI: https://doi.org/10.1007/978-981-19-4800-8_16
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-4799-5
Online ISBN: 978-981-19-4800-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)